Episode 96: Revolutionising Mental Health Diagnosis with Brian Leedman from BlinkLab
Brian Leedman is the Chairman of BlinkLab listed on the ASX: BB1. The company was listed on the 4th of April 2024 and is a health technology company focused on diagnosing autism spectrum disorder and ADHD via neurometric testing on smartphones. Brian discussed the company's history and the plans for an FDA trial to validate the technology. He talked about the goals at BlinkLab, partnerships, what the IPO funds will be used for, the team and what investors can expect in the next 12 months.
BlinkLab Website - https://www.blinklab.org/
Sponsors:
The Market Bull Podcast is proudly sponsored by Gryo Drilling. Head to the team at Gyro Drilling for all your mining and exploration needs.
https://gyroaustralia.com.au/
Chapters:
00:00:00 Intro
00:01:12 Who is Brian Leedman
00:02:44 What is BlinkLab (ASX: BB1)
00:05:35 The Technology at BlinkLab
00:10:45 Autism and ADHD screening
00:16:37 What Will IPO Funds Be Used For?
00:22:03 What The Health Industry Thinks of The Technology
00:25:23 Team at BlinkLab
00:31:49 3 Key Takeaways For The Next 12 months.
00:33:22 Follow BB1 and Outro
Follow the Market bull:
YouTube - TheMarketBullPodcast
LinkedIn - themarketbull
Instagram - official_tmbpodcast
TikTok - theofficialtmbpodcast
Twitter - @TheMarketBullAU
Please note, that the topics and stocks discussed in this podcast are not financial or investment advice.
Recorded at Podwave Studios 🎙️
Connect with Ben Kosterich on LinkedIn - Ben Kosterich
Follow Ben Kosterich on Twitter - @KosterichBen
Create your
podcast in
minutes
It is Free